Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and monte carlo simulation

Cornelia Landersdorfer, Martina Kinzig, Jurgen Bulitta, Friedrich Hennig, Ulrike Holzgrabe, Fritz Sorgel, Johannes Gusinde

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

Abstract

Amoxicillin (amoxicilline)-clavulanic acid has promising activity against pathogens that cause bone infections. We present the first evaluation of the bone penetration of a beta-lactam by population pharmacokinetics and pharmacodynamic profiling via Monte Carlo simulations. Twenty uninfected patients undergoing total hip replacement received a single intravenous infusion of 2,000 mg/200 mg amoxicillin-clavulanic acid before surgery. Blood and bone specimens were collected. Bone samples were pulverized under liquid nitrogen with a cryogenic mill, including an internal standard. The drug concentrations in serum and total bone were analyzed by liquid chromatography-tandem mass spectrometry. We used NONMEM and S-ADAPT for population pharmacokinetic analysis and a target time of the non-protein-bound drug concentration above the MIC for Y50 of the dosing interval for near-maximal bactericidal activity in serum. The median of the ratio of the area under the curve (AUC) for bone/AUC for serum was 20 (10th to 90th percentile for between-subject variability [variability], 16 to 25 ) in cortical bone and 18 (variability, 11 to 29 ) in cancellous bone for amoxicillin and 15 (variability, 11 to 21 ) in cortical bone and 10 (variability, 5.1 to 21 ) in cancellous bone for clavulanic acid. Analysis in S-ADAPT yielded similar results. The equilibration half-lives between serum and bone were 12 min for amoxicillin and 14 min for clavulanic acid. For a 30-min infusion of 2,000 mg/200 mg amoxicillin-clavulanic acid every 4 h, amoxicillin achieved robust (a?Y90 ) probabilities of target attainment (PTAs) for MICs of 12 mg/liter in serum and 2 to 3 mg/liter in bone and population PTAs above 95 against methicillin-susceptible Staphylococcus aureus in bone and serum. The AUC of amoxicillin-clavulanic acid was 5 to 10 times lower in bone than in serum, and amoxicillin-clavulanic acid achieved a rapid equilibrium and favorable population PTAs against pathogens commonly encountered in bone infections.
Original languageEnglish
Pages (from-to)2569 - 2578
Number of pages10
JournalAntimicrobial Agents and Chemotherapy
Volume53
Issue number6
DOIs
Publication statusPublished - 2009

Cite this